7.32
price up icon0.97%   0.07
after-market 시간 외 거래: 7.42 0.10 +1.37%
loading
전일 마감가:
$7.25
열려 있는:
$7.28
하루 거래량:
5.72M
Relative Volume:
1.35
시가총액:
$1.54B
수익:
$557.51M
순이익/손실:
$-35.71M
주가수익비율:
-40.67
EPS:
-0.18
순현금흐름:
$15.50M
1주 성능:
+1.67%
1개월 성능:
-3.56%
6개월 성능:
-17.29%
1년 성능:
-8.61%
1일 변동 폭
Value
$7.18
$7.47
1주일 범위
Value
$7.17
$7.47
52주 변동 폭
Value
$6.00
$11.31

바이오크리스트 Stock (BCRX) Company Profile

Name
명칭
Biocryst Pharmaceuticals Inc
Name
전화
919-859-1302
Name
주소
4505 EMPEROR BOULEVARD, DURHAM, NC
Name
직원
580
Name
트위터
@biocrystpharma
Name
다음 수익 날짜
2025-02-24
Name
최신 SEC 제출 서류
Name
BCRX's Discussions on Twitter

BCRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
BCRX
Biocryst Pharmaceuticals Inc
7.32 1.53B 557.51M -35.71M 15.50M -0.18
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

바이오크리스트 Stock (BCRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-15 재개 TD Cowen Buy
2025-10-01 다운그레이드 Evercore ISI Outperform → In-line
2025-04-29 개시 Cantor Fitzgerald Overweight
2025-02-25 개시 Wedbush Outperform
2023-11-20 재개 JP Morgan Overweight
2023-09-18 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-08-04 업그레이드 Jefferies Hold → Buy
2023-07-13 업그레이드 BofA Securities Neutral → Buy
2023-02-22 업그레이드 Needham Hold → Buy
2022-11-02 업그레이드 Evercore ISI In-line → Outperform
2022-08-05 다운그레이드 Evercore ISI Outperform → In-line
2022-08-05 다운그레이드 Oppenheimer Outperform → Perform
2022-04-18 다운그레이드 Barclays Overweight → Equal Weight
2022-04-11 다운그레이드 BofA Securities Buy → Neutral
2021-12-10 개시 Oppenheimer Outperform
2021-08-06 다운그레이드 Jefferies Buy → Hold
2021-08-03 개시 Cantor Fitzgerald Overweight
2021-03-01 개시 Cowen Outperform
2020-09-29 재개 JP Morgan Overweight
2020-06-17 개시 BTIG Research Neutral
2020-05-05 업그레이드 Barclays Equal Weight → Overweight
2019-11-15 업그레이드 BofA/Merrill Neutral → Buy
2019-05-24 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2018-11-16 재개 Piper Jaffray Overweight
2018-08-08 재개 JP Morgan Overweight
2018-07-17 업그레이드 BofA/Merrill Underperform → Neutral
2018-06-22 개시 Seaport Global Securities Neutral
2018-01-02 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2017-12-20 개시 Barclays Equal Weight
2017-09-15 개시 RBC Capital Mkts Sector Perform
2017-09-06 업그레이드 JP Morgan Neutral → Overweight
2017-09-06 업그레이드 Jefferies Hold → Buy
2017-02-16 개시 Ladenburg Thalmann Buy
2016-08-12 업그레이드 Piper Jaffray Neutral → Overweight
2016-08-04 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 재확인 FBR Capital Outperform
2016-02-09 다운그레이드 JP Morgan Overweight → Neutral
2016-02-09 다운그레이드 Needham Buy → Hold
모두보기

바이오크리스트 주식(BCRX)의 최신 뉴스

pulisher
06:48 AM

Will BioCryst Pharmaceuticals Inc. stock maintain growth storyGlobal Markets & Reliable Intraday Trade Plans - newser.com

06:48 AM
pulisher
06:12 AM

What technical models suggest about BioCryst Pharmaceuticals Inc.’s comebackEarnings Miss & Daily Profit Focused Stock Screening - newser.com

06:12 AM
pulisher
05:13 AM

Is BioCryst Pharmaceuticals Inc. stock bottoming out2025 Momentum Check & Smart Swing Trading Techniques - newser.com

05:13 AM
pulisher
04:40 AM

Is BioCryst Pharmaceuticals Inc. stock ready for a breakoutEarnings Risk Summary & Real-Time Price Movement Reports - newser.com

04:40 AM
pulisher
12:53 PM

Why retail investors pile into BioCryst Pharmaceuticals Inc. stock2025 Short Interest & Verified Technical Signals - newser.com

12:53 PM
pulisher
Oct 30, 2025

Will BioCryst Pharmaceuticals Inc. stock attract ESG investorsMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Why BioCryst Pharmaceuticals Inc. stock could benefit from AI revolutionWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

# BioCryst’s SWOT analysis: stock positioned for growth amid HAE market expansion - Investing.com

Oct 30, 2025
pulisher
Oct 29, 2025

BioCryst Pharmaceuticals (BCRX) Price Target Increased by 19.59% to 21.51 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

BioCryst Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Why BioCryst Shares Plunged - AOL.com

Oct 28, 2025
pulisher
Oct 28, 2025

Aug Shorts: Why hedge funds are buying BioCryst Pharmaceuticals Inc. stockTrade Entry Report & Weekly Stock Performance Updates - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

When is the best time to exit BioCryst Pharmaceuticals Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy? - sharewise.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will BioCryst Pharmaceuticals Inc. stock outperform international peersPortfolio Update Report & AI Optimized Trading Strategy Guides - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

BioCryst Pharmaceuticals (BCRX) Projected to Post Earnings on Monday - MarketBeat

Oct 27, 2025

바이오크리스트 (BCRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

바이오크리스트 주식 (BCRX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
HEGGIE THERESA
Director
Aug 13 '25
Sale
8.51
70,000
595,868
65,352
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
자본화:     |  볼륨(24시간):